Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopain phase IIb exploratory study in chronic osteoarthritic knee pain
2018-000818-37Phase 2Completed
- Sponsor
- Grünenthal GmbH
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Lopain in knee osteoarthritis (OA) (3 arms), sponsored by Grünenthal GmbH. Primary endpoint: Absolute reduction of pain on motion VAS score. Started Apr 2018; status: completed.
02
Drugs
Lopain
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2018-000818-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000818-37.